Biograil’s BIONDD® Platform: Transforming Injectables into Efficient and Convenient Oral Therapy
Thu, Oct 29
|
02:45 PM - 03:00 PM
Gardner
Session details:
Biograil’s BIONDD® platform transforms injectables into efficient and convenient oral therapy delivered from a device housed in a small, easy-to-swallow capsule achieving similar exposure profile as SC injection while improving treatment options, convenience and patient experience.
This presentation will address:
How does BIONDD® compare to marketed oral technologies for GLP-1? Can marketed absorption enhancer technologies achieve the same? Can antibodies and RNA and larger proteins be delivered from the technology?
Many pharma companies have tried to find an efficient oral technology for biologics and has failed. Why do Biograil believe you have a unique solution to the challenge?
What is the regulatory pathway for BIONDD®?
